Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Calgary
$27,000.00
Investigating the role of breast milk immunoglobulin G in early life immune priming
EF 2025-26
Résumé
Infants have a largely naïve immune system and so rely on maternal factors for protection. Specific protection is provided in the form of antibodies (Ab) delivered both through the breast milk (BM) and across the placenta, these include IgG and IgA. Some have suggested that this protection from pathogens can simultaneously reduce the efficacy of vaccines, like that of rotavirus (RV). However, not only has withholding BM shown no clinical benefit for early-life vaccinations, mouse data from the host lab suggest that BM Ab may in fact help the infant's own immune response to RV infection. Indeed, recent findings suggest an active, educational role for BM IgG, which can be taken up by the intestinal neonatal Fc receptor (nFcR) into the blood of the infant. The affinity of IgG for the nFcR is modulated by IgG subclasses and sugar residues on the IgG molecule (glycosylation), however, how these impact BM IgG’s uptake into the infant remain unknown. Understanding when and how environmental factors like maternal Ab influence early-life immunity is of critical importance in rational vaccine design for infants, with IgG potentially even acting as a natural adjuvant. In my project, I aim to define the kinetics and the extent of nFcR-dependent BM IgG uptake into breastfeeding mice by comparing levels of different BM IgG and concentrations of different IgG subclasses in young mice with and without the nFcR. To understand the relevance of previous findings gained through mouse models for human health, I next plan to establish methods to measure and purify RV-specific IgG from human BM. Lastly, I aim to define the specific characteristics of these purified IgG Ab that excel at crossing the human intestine by measuring uptake in model intestines, i.e., organoids.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
573295
Name
Willson Julia B
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of breast milk immunoglobulin G in early life immune priming
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Breast Milk; Glycosylation; Iga; Igg; Immunity; Infant; Infection; Neonatal Fc Receptor; Rotavirus; Small Intestine
Abstract
Infants have a largely naïve immune system and so rely on maternal factors for protection. Specific protection is provided in the form of antibodies (Ab) delivered both through the breast milk (BM) and across the placenta, these include IgG and IgA. Some have suggested that this protection from pathogens can simultaneously reduce the efficacy of vaccines, like that of rotavirus (RV). However, not only has withholding BM shown no clinical benefit for early-life vaccinations, mouse data from the host lab suggest that BM Ab may in fact help the infant's own immune response to RV infection. Indeed, recent findings suggest an active, educational role for BM IgG, which can be taken up by the intestinal neonatal Fc receptor (nFcR) into the blood of the infant. The affinity of IgG for the nFcR is modulated by IgG subclasses and sugar residues on the IgG molecule (glycosylation), however, how these impact BM IgG’s uptake into the infant remain unknown. Understanding when and how environmental factors like maternal Ab influence early-life immunity is of critical importance in rational vaccine design for infants, with IgG potentially even acting as a natural adjuvant. In my project, I aim to define the kinetics and the extent of nFcR-dependent BM IgG uptake into breastfeeding mice by comparing levels of different BM IgG and concentrations of different IgG subclasses in young mice with and without the nFcR. To understand the relevance of previous findings gained through mouse models for human health, I next plan to establish methods to measure and purify RV-specific IgG from human BM. Lastly, I aim to define the specific characteristics of these purified IgG Ab that excel at crossing the human intestine by measuring uptake in model intestines, i.e., organoids.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Willson, Julia B
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~